REVVITY, INC. RVTY
NYSE · XNYS · stock · Laboratory Analytical Instruments · website · IPO 1965-07-06
REVVITY, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | — | — | — | 60.1% | 63.6% |
| Operating margin | 12.5% | 12.6% | 10.9% | 22.4% | 32.9% |
| Net margin | 8.4% | 9.8% | 25.2% | 17.2% | 24.6% |
| FCF margin | 18.0% | 21.0% | 7.2% | 17.9% | 34.6% |
| Return on assets | 2.0% | 2.2% | 5.1% | 4.0% | 6.3% |
| Return on equity | 3.3% | 3.5% | 8.8% | 7.7% | 13.2% |
| Debt / equity | 0.36× | 0.41× | 0.50× | 0.60× | 0.70× |
| Current ratio | 1.68 | 3.60 | 2.07 | 2.13 | 2.01 |
| Revenue growth | 3.7% | 0.2% | -16.9% | -13.5% | 1.2% |
Source: SEC EDGAR filings · CIK 0000031791 · as of 2025-12-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.